B1S Stock Overview

Develops digital pharmaceutical platform for pharmaceutical companies, distributors, vendors, pharmacies, and primary healthcare institutions in China. More details

B1S fundamental analysis
Snowflake Score
Valuation	4/6
Future Growth	0/6
Past Performance	2/6
Financial Health	4/6
Dividends	0/6

Rewards

Trading at 52% below our estimate of its fair value

Became profitable this year

Risk Analysis

Volatile share price over the past 3 months compared to the German market

Large one-off items impacting financial results

Shareholders have been diluted in the past year

My Notes

Capture your thoughts, links and company narrative

YSB Inc. Competitors

Medios

XTRA:ILM1

€294.9m

HAEMATO

HMSE:HAEK

€56.5m

M1 Kliniken

XTRA:M12

€300.6m

RHÖN-KLINIKUM

XTRA:RHK

€937.1m

Price History & Performance

Summary of share price highs, lows and changes for YSB
Historical stock prices
Current Share Price	HK$0.72
52 Week High	HK$0.98
52 Week Low	HK$0.64
Beta	0
1 Month Change	-3.36%
3 Month Change	-7.69%
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	-26.53%

Recent updates

Shareholder Returns

	B1S	DE Healthcare	DE Market
7D	13.4%	-0.2%	-1.1%
1Y	n/a	21.3%	8.1%

Return vs Industry: Insufficient data to determine how B1S performed against the German Healthcare industry.

Return vs Market: Insufficient data to determine how B1S performed against the German Market.

Price Volatility

Is B1S's price volatile compared to industry and market?
B1S volatility
B1S Average Weekly Movement	7.9%
Healthcare Industry Average Movement	4.3%
Market Average Movement	4.9%
10% most volatile stocks in DE Market	11.8%
10% least volatile stocks in DE Market	2.5%

Stable Share Price: B1S's share price has been volatile over the past 3 months compared to the German market.

Volatility Over Time: B1S's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of German stocks.

About the Company

Founded	Employees	CEO	Website
2015	6,513	Buzhen Zhang	www.ysbang.cn

YSB Inc. develops digital pharmaceutical platform for pharmaceutical companies, distributors, vendors, pharmacies, and primary healthcare institutions in China. The company develops ClouDiagnos for diagnostic testing service; wePharmacy, a 24-hour access smart unmanned pharmaceutical booth that connects buyers and the end customers with pharmacist services; SaaS solutions; and YSB eLearn that provides online courses for the preparation of the pharmacist qualification examinations. It also engages in the wholesale and retail of pharmaceutical and healthcare products.

YSB Inc. Fundamentals Summary

How do YSB's earnings and revenue compare to its market cap?
B1S fundamental statistics
Market cap	€513.39m
Earnings (TTM)	€157.46k
Revenue (TTM)	€2.33b

3,260x

P/E Ratio

0.2x

P/S Ratio

Is B1S overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
B1S income statement (TTM)
Revenue	CN¥17.82b
Cost of Revenue	CN¥16.01b
Gross Profit	CN¥1.81b
Other Expenses	CN¥1.80b
Earnings	CN¥1.20m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	0.0018
Gross Margin	10.13%
Net Profit Margin	0.0068%
Debt/Equity Ratio	1.5%

How did B1S perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/17 12:22
End of Day Share Price	2024/12/17 00:00
Earnings	2024/06/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

YSB Inc. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
null null	CMB International Securities Limited

YSB DB:B1S Stock Report